Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Amye L Leong"'
Autor:
Jasvinder A Singh, Liana Fraenkel, Candace Green, Graciela S Alarcón, Jennifer L Barton, Kenneth G Saag, Leslie M Hanrahan, Sandra C Raymond, Robert P Kimberly, Amye L Leong, Elyse Reyes, Richard L Street, Maria E Suarez-Almazor, Guy S Eakin, Laura Marrow, Charity J Morgan, Brennda Caro, Jeffrey A Sloan, Bochra Jandali, Salvador R Garcia, Jennifer Grossman, Kevin L Winthrop, Laura Trupin, Maria Dall'Era, Alexa Meara, Tara Rizvi, W Winn Chatham, Jinoos Yazdany
Publikováno v:
PLoS Medicine, Vol 16, Iss 5, p e1002800 (2019)
BackgroundTreatment decision-making regarding immunosuppressive therapy is challenging for individuals with lupus. We assessed the effectiveness of a decision aid for immunosuppressive therapy in lupus nephritis.Methods and findingsIn a United States
Externí odkaz:
https://doaj.org/article/80c34e59863941a9b74c645f9b11ae86
Autor:
Lee S. Simon, Maarten Boers, Daniel E. Furst, Niti Goel, Maria E. Suarez-Almazor, Paula R Williamson, Amye L. Leong, Thasia G. Woodworth, Robin Christensen, Beverley Shea, Peter Brooks, Dan Devoe, Philip G. Conaghan, John P. A. Ioannidis, Peter Tugwell, Caroline B. Terwee, Dorthe B. Berthelsen, Vibeke Strand
Publikováno v:
Berthelsen, D B, Woodworth, T G, Goel, N, Ioannidis, J P A, Tugwell, P, Devoe, D, Williamson, P, Terwee, C B, Suarez-Almazor, M E, Strand, V, Leong, A L, Conaghan, P G, Boers, M, Shea, B J, Brooks, P M, Simon, L S, Furst, D E, Christensen, R & OMERACT Safety Working Group 2021, ' Harms reported by patients in rheumatology drug trials : a systematic review of randomized trials in the cochrane library from an OMERACT working group ', Seminars in Arthritis and Rheumatism, vol. 51, no. 3, pp. 607-617 . https://doi.org/10.1016/j.semarthrit.2020.09.023
OMERACT Safety Working Group 2021, ' Harms reported by patients in rheumatology drug trials : a systematic review of randomized trials in the cochrane library from an OMERACT working group ', Seminars in Arthritis and Rheumatism, vol. 51, no. 3, pp. 607-617 . https://doi.org/10.1016/j.semarthrit.2020.09.023
OMERACT Safety Working Group 2021, ' Harms reported by patients in rheumatology drug trials : a systematic review of randomized trials in the cochrane library from an OMERACT working group ', Seminars in Arthritis and Rheumatism, vol. 51, no. 3, pp. 607-617 . https://doi.org/10.1016/j.semarthrit.2020.09.023
Background Underreporting of harms in randomized controlled trials (RCTs) may lead to incomplete or erroneous assessments of the perceived benefit-to-harm profile of an intervention. To compare benefit with harm in clinical practice and future clinic
Autor:
Dan Devoe, Kathleen M. Andersen, Niti Goel, Daniel E. Furst, Robin Christensen, Dorthe B. Berthelsen, Victor S. Sloan, Peter Brooks, Paula R Williamson, Louise Klokker, Amye L. Leong, Lee S. Simon, Thasia G. Woodworth, Maria E. Suarez-Almazor, Vibeke Strand, Maarten Boers, Lyn March, Peter Tugwell
Publikováno v:
JOURNAL OF RHEUMATOLOGY
Klokker, L, Berthelsen, D B, Woodworth, T, Andersen, K M, Furst, D E, Devoe, D, Williamson, P R, Suarez-Almazor, M E, Strand, V, Leong, A L, Goel, N, Boers, M, Brooks, P M, March, L, Sloan, V S, Tugwell, P, Simon, L S & Christensen, R 2019, ' Identifying possible outcome domains from existing outcome measures to inform an OMERACT core domain set for safety in rheumatology trials ', Journal of Rheumatology, vol. 46, no. 9, pp. 1173-1178 . https://doi.org/10.3899/jrheum.190196
Journal of Rheumatology, 46(9), 1173-1178. Journal of Rheumatology
Klokker, L, Berthelsen, D B, Woodworth, T, Andersen, K M, Furst, D E, Devoe, D, Williamson, P R, Suarez-Almazor, M E, Strand, V, Leong, A L, Goel, N, Boers, M, Brooks, P M, March, L, Sloan, V S, Tugwell, P, Simon, L S & Christensen, R 2019, ' Identifying possible outcome domains from existing outcome measures to inform an OMERACT core domain set for safety in rheumatology trials ', Journal of Rheumatology, vol. 46, no. 9, pp. 1173-1178 . https://doi.org/10.3899/jrheum.190196
Journal of Rheumatology, 46(9), 1173-1178. Journal of Rheumatology
Objective.The Outcome Measures in Rheumatology (OMERACT) Safety Working Group objective was to identify harm domains from existing outcome measurements in rheumatology.Methods.Systematically searching the MEDLINE database on January 24, 2017, we iden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e52e6daf1932f4d6a557453ad35aed47
Autor:
Guy Eakin, Jeff A. Sloan, Alexa Meara, Leslie Hanrahan, Jennifer L. Barton, Maria Dall'Era, Salvador Garcia, Kevin L. Winthrop, Bochra Jandali, Tara Rizvi, Candace Green, Jasvinder A. Singh, Elyse Reyes, Sandra Raymond, Charity J. Morgan, Jennifer M. Grossman, Liana Fraenkel, Kenneth G. Saag, Jinoos Yazdany, W. Winn Chatham, Graciela S. Alarcón, Brennda Caro, Laura Marrow, Laura Trupin, Robert P. Kimberly, Richard L. Street, Maria E. Suarez-Almazor, Amye L. Leong
Publikováno v:
PLoS medicine, vol 16, iss 5
PLoS Medicine, Vol 16, Iss 5, p e1002800 (2019)
PLoS Medicine
PLoS Medicine, Vol 16, Iss 5, p e1002800 (2019)
PLoS Medicine
Background Treatment decision-making regarding immunosuppressive therapy is challenging for individuals with lupus. We assessed the effectiveness of a decision aid for immunosuppressive therapy in lupus nephritis. Methods and findings In a United Sta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::204f8bcac97064553f332c44c4edb476
https://escholarship.org/uc/item/5xx5c1r8
https://escholarship.org/uc/item/5xx5c1r8
Autor:
Lee S. Simon, Amye L. Leong, Thasia G. Woodworth, Robin Christensen, Caroline B. Terwee, Maarten Boers, Paula R Williamson, Dan Devoe, Vibeke Strand, Niti Goel, Daniel E. Furst, Peter Brooks, L. Klokker, Peter Tugwell, Maria E. Suarez-Almazor
Publikováno v:
Journal of Rheumatology, 44(12), 1916-1919. Journal of Rheumatology
Klokker, L, Tugwell, P, Furst, D E, Devoe, D, Williamson, P, Terwee, C B, Suarez-Almazor, M E, Strand, V, Woodworth, T, Leong, A L, Goel, N, Boers, M, Brooks, P M, Simon, L S & Christensen, R 2017, ' Developing an OMERACT core outcome set for assessing safety components in rheumatology trials : The OMERACT safety working group ', Journal of Rheumatology, vol. 44, no. 12, pp. 1916-1919 . https://doi.org/10.3899/jrheum.161105
Klokker, L, Tugwell, P, Furst, D E, Devoe, D, Williamson, P, Terwee, C B, Suarez-Almazor, M E, Strand, V, Woodworth, T, Leong, A L, Goel, N, Boers, M, Brooks, P M, Simon, L S & Christensen, R 2017, ' Developing an OMERACT core outcome set for assessing safety components in rheumatology trials : The OMERACT safety working group ', Journal of Rheumatology, vol. 44, no. 12, pp. 1916-1919 . https://doi.org/10.3899/jrheum.161105
Objective.Failure to report harmful outcomes in clinical research can introduce bias favoring a potentially harmful intervention. While core outcome sets (COS) are available for benefits in randomized controlled trials in many rheumatic conditions, l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b14a17dca1e1477c3c754577db660ee
https://research.vumc.nl/en/publications/36e5798d-900f-4769-8370-ef7d87bfb59a
https://research.vumc.nl/en/publications/36e5798d-900f-4769-8370-ef7d87bfb59a
Autor:
Dorcas E. Beaton, Amye L. Leong, Caroline A Flurey, Marieke Voshaar, Annelies Boonen, Thasia G. Woodworth, Daniel E. Furst, Suzanne M M Verstappen, Christoph Pohl, P. Tugwell, Nataliya Milman, Monika E. Finger, Sabrina Mai Nielsen, Francis Guillemin, Reuben Escorpizo, Lyn March, Margreet Kloppenburg, Rieke Alten, Robin Christensen
Publikováno v:
Journal of Rheumatology
Journal of Rheumatology, Journal of Rheumatology Publishing Company Limited, 2017, 44 (11), pp.1734-1739. ⟨10.3899/jrheum.161200⟩
Journal of Rheumatology, 44(11), 1734-1739. Journal of Rheumatology Publishing Co. Ltd.
Finger, M E, Boonen, A, Woodworth, T, Escorpizo, R, Christensen, R, Nielsen, S M, Leong, A, Scholte Voshaar, M, Flurey, C, Milman, N, Verstappen, S, Alten, R, Guillemin, F, Kloppenburg, M, Beaton, D, Tugwell, P, March, L, Furst, D E & Pohl, C 2017, ' An OMERACT Initiative Towards Consensus to Identify and Characterize Candidate Contextual Factors: Report from the Contextual Factors Working Group ', Journal of Rheumatology, vol. 44, no. 11, pp. 1734-1739 . https://doi.org/10.3899/jrheum.161200
Journal of Rheumatology, 44(11), 1734-1739
Journal of Rheumatology, Journal of Rheumatology Publishing Company Limited, 2017, 44 (11), pp.1734-1739. ⟨10.3899/jrheum.161200⟩
Journal of Rheumatology, 44(11), 1734-1739. Journal of Rheumatology Publishing Co. Ltd.
Finger, M E, Boonen, A, Woodworth, T, Escorpizo, R, Christensen, R, Nielsen, S M, Leong, A, Scholte Voshaar, M, Flurey, C, Milman, N, Verstappen, S, Alten, R, Guillemin, F, Kloppenburg, M, Beaton, D, Tugwell, P, March, L, Furst, D E & Pohl, C 2017, ' An OMERACT Initiative Towards Consensus to Identify and Characterize Candidate Contextual Factors: Report from the Contextual Factors Working Group ', Journal of Rheumatology, vol. 44, no. 11, pp. 1734-1739 . https://doi.org/10.3899/jrheum.161200
Journal of Rheumatology, 44(11), 1734-1739
Objective.The importance of contextual factors (CF) for appropriate patient-specific care is widely acknowledged. However, evidence in clinical trials on how CF influence outcomes remains sparse. The 2014 Outcome Measures in Rheumatology (OMERACT) Ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9753df3e60b8def20c159568305e5210
https://doi.org/10.3899/jrheum.161200
https://doi.org/10.3899/jrheum.161200
Autor:
Michael Dohm, Marieke Voshaar, Peter F. M. Choong, Jasvinder A. Singh, Susan M. Goodman, Amye L. Leong, Michelle M. Dowsey
Publikováno v:
The Journal of rheumatology. 44(11)
Objective.Discussion and endorsement of the OMERACT total joint replacement (TJR) core domain set for total hip replacement (THR) and total knee replacement (TKR) for endstage arthritis; and next steps for selection of instruments.Methods.The OMERACT
Autor:
Thasia G. Woodworth, Daniel E. Furst, Robin Christensen, Anne Lyddiatt, Vivian P. Bykerk, Clifton O. Bingham, Alfons den Broeder, Sarah Hewlett, Pamela Montie, Francis Guillemin, Christoph Pohl, Rieke Alten, Bruno Fautrel, Marieke Voshaar, Susan J. Bartlett, Skye Barbic, Lyn March, Amye L. Leong, Ernest Choy
Publikováno v:
The Journal of Rheumatology, 44, 10, pp. 1536-1543
The Journal of Rheumatology, 44, 1536-1543
Journal of Rheumatology
Journal of Rheumatology, Journal of Rheumatology Publishing Company Limited, 2017, 44 (10), pp.1536-1543. ⟨10.3899/jrheum.161145⟩
The Journal of Rheumatology, 44, 1536-1543
Journal of Rheumatology
Journal of Rheumatology, Journal of Rheumatology Publishing Company Limited, 2017, 44 (10), pp.1536-1543. ⟨10.3899/jrheum.161145⟩
Objective.The Outcome Measures in Rheumatology (OMERACT) Rheumatoid Arthritis (RA) Flare Group was established to develop a reliable way to identify and measure RA flares in randomized controlled trials (RCT). Here, we summarized the development and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff1f5e8d4829df4899422b69cbf49106
https://hdl.handle.net/2066/178227
https://hdl.handle.net/2066/178227
Autor:
Marieke Voshaar, Susan J. Bartlett, Daniel E. Furst, Pam Montie, Anne Lyddiatt, Thasia G. Woodworth, Elisabeth Lie, Sarah Hewlett, Vivian P. Bykerk, Amye L. Leong, Lyn March, Christoph Pohl, Rieke Alten, Clifton O. Bingham, Annelies Boonen, Ernest Choy, Robin Christensen, Ana Maria Orbai, James E. May
Publikováno v:
Journal of Rheumatology, 41(4), 799-809. Journal of Rheumatology Publishing Co. Ltd.
Objective.The OMERACT Rheumatoid Arthritis (RA) Flare Group (FG) is developing a data-driven, patient-inclusive, consensus-based RA flare definition for use in clinical trials, longterm observational studies, and clinical practice. At OMERACT 11, we
Autor:
Amye L. Leong, Premarani Sinnathurai, Rieke Alten, Serena Halls, Clifton O. Bingham, Sarah Hewlett, Susan J. Bartlett, Rod Hughes, Lorna Neill, John R. Kirwan, Anne Lyddiatt, Christopher Hill, Lyn March, Sarah L. Mackie, Ying Ying Leung, Ina Campbell, Robert J. Holt, Ana Maria Orbai
Publikováno v:
The Journal of rheumatology. 44(12)
Objective.The objectives of the Outcome Measures in Rheumatology (OMERACT) Stiffness special interest group (SIG) are to characterize stiffness as an outcome in rheumatic disease and to identify and validate a stiffness patient-reported outcome (PRO)